Cannara Biotech Inc (TSXV:LOVE)
C$ 0.69 0 (0%) Market Cap: 62.11 Mil Enterprise Value: 108.43 Mil PE Ratio: 11.50 PB Ratio: 0.78 GF Score: 55/100

Q2 2023 Cannara Biotech Inc Earnings Call Transcript

May 04, 2023 / 06:00PM GMT
Release Date Price: C$0.82
Operator

Greetings, and welcome to the Cannara Biotech investor presentation. (Operator Instructions) Please note that this conference is being recorded.

I will now turn the conference over to our host, Glen Akselrod, President, Bristol Capital. Thank you. You may begin.

Glen Akselrod
Bristol Capital - President

Thank you, Diego, and thank you, everybody, for joining our webcast today with Cannara Biotech. The purpose of today's presentation is to give our audience a better understanding of the business through a PowerPoint presentation and then questions with management. The discussion is going to be led by Nicholas Sosiak, CFO. You should see the presentation in the webcast.

If you'd like, a copy of this PowerPoint, simply e-mail me at [email protected]. I'll be happy to send you one. We'll break for questions at the end of the formal presentation. When we do break, we encourage those questions. And as a reminder, we're only taking questions through the web portal.

If you're listening over the telephone, please access the web link that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot